Adjunctive Argatroban and Eptifibatide Fails to Show Benefit in Reducing Poststroke Disability in Phase 3 Study

Published Date: 15 Sep 2024

Results revealed that adjunctive treatment with intravenous argatroban or eptifibatide was associated with increased mortality in acute ischemic stroke treated with intravenous thrombolysis.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.

2.

Even a few mutated cells can significantly impact how blood cancers develop, study finds

3.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

4.

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

5.

In Acute Leukemia With Heavily Pretreated Patients, Menin Inhibitor Yields 63 Percent ORR.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot